C
Description
Hyderabad company focused on the development and supply of active pharmaceutical ingredients, backed by a business house with more than four decades in the sector. Its published portfolio covers the cardiovascular, central nervous system, metabolic and anaesthetic segments, with molecules including olmesartan medoxomil, lacosamide, levetiracetam, risperidone, warfarin sodium, voglibose, vildagliptin, linagliptin, loxoprofen and tetracaine.